novo nordisk's semaglutide failed to slow alzheimer's disease progression reports 2 trial failures for GLP-1 in Alzheimer's patients treated with the

It plays a central role in: Converting food into usable energy (ATP) Repairing damaged DNA Supporting brain function, memory, and focus Boosting metabolism and cellular health Slowing the effects of aging on the skin and body Unfortunately, our NAD+ levels naturally decline with ageleading to symptoms like chronic fatigue, mental fog, weight gain, and reduced skin elasticity

Improved lean body mass and insulin sensitivity Vittone J et al

Labeling GLP-1s a shortcut ignores the reality of chronic disease care

Testosterone Options *Disclaimer: "TRT or B12 Included In Program - No Additional Charge!" requires provider approval before starting treatment

The short truth is: most single natural interventions do not match the mean effects of modern injectable medications